What is the main business of Medomnis?

The main business activity of Medomnis focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 11, 2019.

Where is the headquarters located?

The headquarters is located at: ul. Kierska 28, 62-090 Kiekrz.

What is the share capital?

The share capital of the company is PLN 6,000 (approx. $1,621).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.

What revenue was generated?

The company reported a revenue of $45 in 2021, which is an increase of 47418.9% compared to 2020.

Is the company profitable?

No, the company recorded a net loss of $631 in 2021. For comparison, in 2020 the loss was $1,735, meaning the company reduced its loss by 64.0%.

Medomnissp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2019-12-11

Share capital

6 000,00 PLN

Registered address

ul. Kierska 28, 62-090 Kiekrz, Poland

Financials

Revenue history

Filing timeliness

No financial statement for 2022 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2021, 20 days late).

2022not filed
202104/08/2022
202005/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue

This companyUSD 45.49MedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD -630.93MedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 676.43MedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 1.03kMedianUSD 609.79kAverageUSD 11.85m

Industry

Authorized Representatives

Kazimierz Gerard Strzyżewski – Attorney-in-fact (sole)

Jan Piotr Rogala – Vice President of the Management Board

Piotr Rogala – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations of will on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Jan Piotr Rogalaage 40	80	$1,080.50	66.6667%
Piotr Rogalaage 80	40	$540.25	33.3333%

Jan Piotr Rogala and Piotr Rogala hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-01-16 to 2023-06-29.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
Nov 17, 2025	Dissolution without liquidation opened

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Sonomedical Pluciński, Wojciechowski, Wituskisp. j.	$1,264,523.63	sonomedical.pl
Medaidsp. z o.o.	$1,034,514.88	medaid.pl
Meditechsp. z o.o.	$934,565.46	meditech.pl
PNN Pharmaceuticals sp. z o.o.sp. k.	$267,897.16	pnn.com.pl
Medicallenssp. z o.o.	$179,960.83	medicallens.com
Integris Medical Polskasp. z o.o.	$159,033.76	integrismedical.pl
Aptekssp. z o.o.	$13,537.42	apteks.com
HA Technologiessp. z o.o.	$206.67	amalian.pl
Medventissp. z o.o.	–	medventis.pl
LAB Path Expertssp. z o.o.	–	labpathexperts.com

FAQ

Last updated: 2026-04-16